BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24485022)

  • 41. Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials.
    Han XF; Zhang XX; Liu KM; Tan H; Zhang Q
    PLoS One; 2018; 13(3):e0194330. PubMed ID: 29558481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
    Müller FH
    Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.
    Castaldo P; Frascà GM; Brigante F; Ferrante L; Magi S; Pavani M; Skrami E; Giuseppetti GM; Polonara G; Amoroso S
    Eur Radiol; 2019 Jul; 29(7):3927-3934. PubMed ID: 30989349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
    Lencioni R; Fattori R; Morana G; Stacul F
    Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low osmolar (non-ionic) contrast media versus high osmolar (ionic) contrast media in intravenous urography and enhanced computerized tomography: a cost-effectiveness analysis.
    Wangsuphachart S
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):664-76. PubMed ID: 1820658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review of cost-effectiveness analyses across the acute kidney injury landscape.
    Suh K; Kellum JA; Kane-Gill SL
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):571-578. PubMed ID: 33522323
    [No Abstract]   [Full Text] [Related]  

  • 48. The relative renal safety of iodixanol compared with low-osmolar contrast media.
    Cantor E; Lim L
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1163-4; author reply 1164. PubMed ID: 19926063
    [No Abstract]   [Full Text] [Related]  

  • 49. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations.
    Häussler MD
    Acta Radiol; 2010 Oct; 51(8):924-33. PubMed ID: 20828300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
    Hafiz AM; Jan MF; Mori N; Shaikh F; Wallach J; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2012 May; 79(6):929-37. PubMed ID: 21542114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats.
    Jost G; Pietsch H; Sommer J; Sandner P; Lengsfeld P; Seidensticker P; Lehr S; Hütter J; Sieber MA
    Invest Radiol; 2009 Feb; 44(2):114-23. PubMed ID: 19104440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL; Marti-Bonmati L; Lim L; Becker HC
    Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
    Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
    AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
    [No Abstract]   [Full Text] [Related]  

  • 60. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.
    Limbruno U; Picchi A; Micheli A; Calabria P; Cortese B; Brizi G; Severi S; De Caterina R
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):587-94. PubMed ID: 23811842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.